Skip to main content
SpringerLink
Log in

Examining country-level decisions on introducing HPV vaccine 2006−2018

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jit M. Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018. Value in Health : 16 Oct 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.07.012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Examining country-level decisions on introducing HPV vaccine 2006−2018. PharmacoEcon Outcomes News 865, 15 (2020). https://doi.org/10.1007/s40274-020-7239-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7239-x

Search

Navigation